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A procedure for the identiﬁcation of ligands bound in crystal
structures of macromolecules is described. Two characteristics
of the density corresponding to a ligand are used in the
identiﬁcation procedure. One is the correlation of the ligand
density with each of a set of test ligands after optimization of
the ﬁt of that ligand to the density. The other is the correlation
of a ﬁngerprint of the density with the ﬁngerprint of model
density for each possible ligand. The ﬁngerprints consist of an
ordered list of correlations of each the test ligands with the
density. The two characteristics are scored using a Z-score
approach in which the correlations are normalized to the mean
and standard deviation of correlations found for a variety of
mismatched ligand-density pairs, so that the Z scores are
related to the probability of observing a particular value of the
correlation by chance. The procedure was tested with a set of
200 of the most commonly found ligands in the Protein Data
Bank, collectively representing 57% of all ligands in the
Protein Data Bank. Using a combination of these two
characteristics of ligand density, ranked lists of ligand iden-
tiﬁcations were made for representative (Fo   Fc)exp(i’c)
difference density from entries in the Protein Data Bank. In
48% of the 200 cases, the correct ligand was at the top of the
ranked list of ligands. This approach may be useful in
identiﬁcation of unknown ligands in new macromolecular
structures as well as in the identiﬁcation of which ligands in a
mixture have bound to a macromolecule.
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1. Introduction
It is common in macromolecular crystal structure determina-
tions to ﬁnd that a small-molecule ligand has been cocrys-
tallized with the macromolecule, even in cases where this
ligand was not known to be present in the crystallization
media. This situation occurs, for example, if the protein has
been expressed in a complicated cell-based system containing
many compounds and some of these compounds bind to the
macromolecule and remain bound throughout puriﬁcation
and crystallization (see, for example, Zarembinski et al., 1998).
The identiﬁcation of the ligand in these cases can be an
important step in characterizing the macromolecule, as it may
give clues as to the natural function of the macromolecule. A
related situation occurs in increasingly many drug-discovery
and ligand-discovery projects in which a mixture of ligands is
included in crystallization or after crystallization, a structure is
determined and the identify of the bound ligand is determined
from the density (see, for example, Tickle et al., 2004).
We have recently developed an approach to the ﬁtting of
ﬂexible ligands to electron-density maps that is well suited to
large-scale automated analyses (Terwilliger et al., 2006). The
ligand-ﬁtting approach is quite similar to the process that anexpert crystallographer would follow; it consists of the iden-
tiﬁcation of an optimal location and orientation of a core
fragment of the ligand within the largest contiguous region of
density in the map, followed by building the remainder of the
ligand by tracing the density out from this core region. We
previously have used this approach to build 9327 ligands from
the Protein Data Bank (PDB; Berman et al., 2000) into
(Fo   Fc)exp(i’c) difference density created by removal of
ligands from entries from the PDB and found that 68% of
these ligands could be rebuilt with an r.m.s.d. from the original
coordinates of 2 A ˚ or less. Several other methods for auto-
matic ﬁtting of ligand density have been developed recently
(Diller et al., 1999; Oldﬁeld, 2001; Zwart et al., 2004) and these
could also most likely be used in the procedures we describe
below.
Here, we evaluate the utilities of two approaches to ligand
identiﬁcation using electron density alone. The ﬁrst approach
is simply to ﬁt each of a large set of possible ligands to the
density and rank these ligands based on the correlation of
calculated and observed density. The second approach extends
this by creating a ‘ﬁngerprint’ of correlations expected for
density from each of a set of possible ligands and comparing
this ﬁngerprint with that obtained using the observed density
in the map to identify the ligand. We test these approaches by
applying them to examples of 200 of the most frequently found
ligands from the PDB.
2. Methods
2.1. Models, structure factors and ligands from the PDB
We began with 27 812 entries from the November 2004
release of the PDB stored in an Oracle database populated,
using version 1.5.1 of the openMMS Toolkit (Greer et al.,
2002), from mmCIF ﬁles obtained at ftp://beta.rcsb.org/pub/
pdb/uniformity/data/mmCIF/divided. We selected the 12 001
entries that contained at least one large polypeptide molecule
(20 or more residues) and one ligand, which we deﬁned as a
nonmacromolecular mmCIF entity with 6–150 non-H atoms
and, if a polypeptide, containing no more than two residues.
From these entries, we selected the 7025 entries that contained
structure-factor amplitudes or intensities that, with minor
automated editing, could be read by the CCP4 program
cif2mtz (Collaborative Computational Project, Number 4,
1994). These 7025 entries contained 23 514 total instances of
ligands, of which 22 562 (96%) could be successfully analyzed
by our algorithms. The 22 562 ligands represent 2740 different
ligand compounds, as deﬁned by an ordered string of
heterocompound codes (one for each residue in the mmCIF
entity). The number of PDB entries containing each ligand
was counted and the most common 200 were noted. These 200
most common ligands in our data set ranged from 658 PDB
entries containing HEM (heme) and 593 with GOL (glycerol)
to six entries with NAG-NAG-BMA. Some of these ligands
had the same number and ordered list (by atom name) of non-
H atoms in each instance, but many had some variability in the
number and listing of non-H atoms, with some instances
missing some or even the majority of atoms compared with
another.For some purposes we further subdivided instances of
each ligand into sets of instances in which both the hetero-
compound string and the list of non-H atom names were
unique, calling these more exacting groupings the set of
‘unique ligands’, of which there were total of 3364 in the
subset of the PDB we analyzed. The 200 unique ligands that
were used in this study account for 57% of all ligands in the
PDB. That is, 22 538 of the 39 607 ligand instances in the entire
PDB match one of these 200 unique ligands both in hetero-
compound string and the list of non-H atoms.
We carried out the ligand-identiﬁcation procedures as
follows. For each of the most common 200 ligands from our
data set, we chose one PDB entry that contained the ligand,
along with that instance of the ligand, as an example. The
examples were chosen arbitrarily (alphabetically) from a list
of all entries that (i) contained the most complete version of
this ligand (i.e. the most atoms) and (ii) had a correlation of
(Fo   Fc)exp(i’c) difference density calculated after removal
of this ligand with model density calculated from the original
ligand from the PDB entry of at least 0.75. If no entry satisﬁed
the second condition, then the entry with the highest value of
the correlation of density was chosen. A total of 200 Fo   Fc
difference density maps were obtained from the 200 ligand–
PDB entry combinations by removal of the ligand followed by
calculation of maps. The corresponding 200 ligands were each
used to ﬁt the 200 difference maps, except that in cases where
a ligand was to be ﬁtted to the PDB entry that it came from, a
second example of that ligand (with the identical listing of
non-H atoms) from a different PDB entry was used as a
starting point for ﬁtting. In this way, the original conformation
could not be simply placed into density without any actual
ﬁtting of torsion angles. If no example from another PDB
entry existed, the rotatable bonds in the ligand were adjusted
arbitrarily before the ligand was used in the ﬁtting procedures.
2.2. Clustering of ligands based on fitting of model ligand
density
To cluster ligands into groups that can be ﬁtted into similar
density, model density was calculated at a resolution of 2.5 A ˚
for one example of each of the most common 200 ligands from
the PDB. All 200 of the most common ligands were then ﬁtted
to this density. Each combination of model density for ligand i
and ﬁtted ligand j was then scored by calculating the corre-
lation of the model densities for ligand i and ﬁtted ligand j.T h e
correlation was calculated over a comparison region deﬁned
as all points within 2.5 A ˚ of an atom in the ﬁtted ligand. This
resulted in a 200   200 matrix ccij of correlation of density for
all ligand pairs. The matrix is not symmetric because the ﬁtting
of ligand i into the density for ligand j is not the same as the
reverse. As we were interested in clustering the ligands based
on effective shape similarities (after adjustment of torsion
angles to match as closely as possible), we averaged the ﬁt of
ligand i into density for ligand j and the ﬁt of ligand j into
density for ligand i, yielding a symmetric similarity matrix
cc
avg
ij .
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PDB using the similarity matrix cc
avg
ij and choosing several
different thresholds for similarity between members of a
cluster and a unique member of that cluster used to represent
the whole cluster. The procedure used in clustering was to ﬁnd
the ligand that had the largest number of values of cc
avg
ij
greater than the threshold and to group all the corresponding
ligands with this unique member. The process was then
repeated with all remaining ligands until none could be clus-
tered.
3. Results and discussion
3.1. Clustering the most common 200 ligands from the PDB
Many of the most common ligands in the PDB are quite
similar to each other. For example, the nucleotides ATP,
ddATP and GTP are all highly similar in shape (Fig. 1). In
order to develop a set of ligands that has less redundancy, the
most common 200 ligands from the PDB were clustered based
on how well each ligand could be ﬁtted into density for
another, as described in x2. Clustering in this way with a
correlation coefﬁcient threshold of 0.85 yielded 119 unique
ligands, with clusters having between one and 18 members.
Clustering with a threshold of 0.75 yielded 31 unique ligands,
with clusters having between one and 110 members.
3.2. Identification of ligands based on correlation of densities
after fitting
A simple approach to identiﬁcation of a ligand from
experimental (Fo   Fc)exp(i’c) electron density would be to
ﬁt a set of candidate ligands to this density, scoring each based
on the correlation of (ﬁtted) model density to the experi-
mental density in the region of the model and choosing the
highest scoring ligands as the most likely to be correct. We
tested this procedure using the set of 119 unique ligands
selected above (obtained by clustering the most common 200
ligands from the PDB at a threshold correlation of 0.85).
For each ligand, a PDB entry containing the ligand was
chosen as described in x2, the ligand was removed from the
entry and (Fo   Fc)exp(i’c) difference density was calculated.
An example of each of the 119 unique ligands (from a
different PDB entry if possible, as described in x2) was then
ﬁtted into this difference density and the correlation of
resulting model density and observed difference density was
calculated.
Fig. 2(a) shows the utility of the correlation coefﬁcient in
identifying ligands based on difference density. For the set of
119 unique ligands, the rank number of the correct ligand (i.e.
that in the PDB entry from which the density was obtained) is
shown. Overall, in 46% of cases the ligand with the highest
correlation was the correct ligand. In most remaining cases the
correct ligand was within the top-ranked few ligands, but some
were as low in rank as number 14.
The reason why some of the ligands could be identiﬁed with
this approach and others could not is likely to be that some
density is relatively unique in shape, allowing substantial
discrimination among ligands, while other density is not and
many ligands can ﬁt into it. Fig. 3 illustrates examples of ligand
density that could be ﬁtted well by only one ligand among the
200 most common from the PDB. Difference density for
bacteriochlorophyll a at a resolution of 2.35 A ˚ (PDB code
1ogv; Katona et al., 2003), for example, is highly distinctive, as
is density for cyclohexyl-hexyl- -d-maltoside at a resolution of
1.1 A ˚ (PDB code 1ong; Nukaga et al., 2003).
Fig. 4 illustrates an example of density that can be ﬁtted by
many ligands. The (Fo   Fc)exp(i’c) difference density for
tris-(hydroxylmethyl)-aminomethane is from PDB entry 1m6z
(A. Noergaard, P. Harris, S. Larsen & H. E. M. Christensen,
unpublished work) at a resolution of 1.4 A ˚ . It can be ﬁtted by
this same ligand (Fig. 4a) with a correlation of 0.72, but it can
also be ﬁtted even better by several other ligands such as
oxalate (Fig. 4b, correlation of 0.76) or dioxane (Fig. 4c,
correlation of 0.76).
3.3. Identification of ligands based on Z scores using
correlation of densities after fitting
Some density can be readily ﬁtted by several ligands as
shown above and conversely some ligands can ﬁt most density
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Figure 1
(a) ATP ﬁtted into model 2.5 A ˚ density for ATP. (b) ddATP ﬁtted into model density for ATP. (c) GTP ﬁtted into model density for ATP.better than other ligands. For example, the mean   SD of
correlation of density after ﬁtting tris-(hydroxylmethyl)-
aminomethane to all 119 unique observed ligand difference
density maps was 0.61   0.08, while the same quantities for
dioxane were 0.68   0.08. Therefore, it might be reasonable to
conclude that a ﬁt of tris-(hydroxylmethyl)-methane that had
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Figure 2
Histograms of rank position of correct ligands. (a) Scoring using correlation of density, considering 119 unique ligands. (b) Scoring using Z score derived
from correlation of density. (c) Scoring using Z score derived from correlation of ﬁngerprints of density and ﬁngerprints of model density. (d) Scoring
using sum of Z scores from correlation of density and correlation of ﬁngerprints of density. (e)A si n( d), but considering all 200 of the most common
ligands in the PDB. (f)A si n( d), but considering only 31 unique ligands.a correlation of 0.61 is approximately equivalent to a ﬁt of
dioxane with a correlation of 0.68. We used a Z-score
approach to carry out this normalization, with the Z score
given by
Zi ¼ð cci  h cciiÞ= ðcciÞ; ð1Þ
where cci is the correlation of model density for ligand i to the
Fo   Fc difference density after ﬁtting and hccii and  (cci) are
the mean and SD of correlations of ligand i to all 119 differ-
ence density maps. In essence, hccii and  (cci) are the mean
and SD of the correlation of ligand i to representative
difference density from the PDB.
Fig. 2(b) shows the use of Z scores based on correlation
coefﬁcient in identifying ligands. The Z-score normalization
increases the percentage of cases where the ligand with the
highest correlation was the correct ligand from 46% to 64%.
3.4. Identification of ligands based on fingerprints of
correlation coefficients
The process of ﬁtting each of 119 ligands to difference
density and obtaining correlation coefﬁcients for each ﬁt
yields some information that we have not taken full advantage
of by simply choosing the highest correlation or Z score to
identify the best-ﬁtting ligand. This additional information is
the pattern of ﬁts of the entire set of 119 ligands. Fig. 5 illus-
trates the ﬁngerprints for difference density for tris-(hydroxyl-
methyl)-methane and for ATP. The correlation coefﬁcients for
each of the 119 ligands are shown, where the ligands are sorted
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Figure 4
Fitting of Fo   Fc difference density for tris-(hydroxylmethyl)-methane from PDB entry 1m6z (A. Noergaard, P. Harris, S. Larsen & H. E. M.
Christensen, unpublished) at a resolution of 1.4 A ˚ .( a) Density ﬁtted by the same ligand from a different PDB entry (1s18; Dai et al., 2004). (b) Density
ﬁtted with oxalate. (c) Density ﬁtted with dioxane.
Figure 3
(a) Fo   Fc difference density for bacteriochlorophyll a at 2.4 A ˚ (PDB code 1ogv; Katona et al., 2003), ﬁtted with the same ligand from PDB entry 1dv6
(Axelrod et al., 2000). (b) Difference density for cyclohexyl-hexyl- -d-maltoside at a resolution of 1.1 A ˚ (PDB code 1ong; Venkatesan et al., 2004), ﬁtted
with the same ligand from PDB entry 1q2p (Nukaga et al., 2003).on the basis of the number of non-H atoms. The ﬁngerprint for
tris-(hydroxylmethyl)-methane shows that many small ligands
ﬁt well to its difference density, while large ligands do not. In
the case of ATP, the pattern is much more complicated, with
some small and some large ligands ﬁtting well and others not.
We use the correlation of the single ﬁngerprint calculated
from the difference density to be identiﬁed, with the ﬁnger-
prints obtained for model density for each of the 119 ligands
considered as a second measure of the compatibility of the
density with each of those 119 ligands. We calculate this as a Z
score in the same fashion as described above for single
correlation coefﬁcients.
Fig. 2(c) shows the use of Z scores based on correlation of
ﬁngerprints derived from difference density with ﬁngerprints
for each ligand using model data. This approach (without
including any Z-score information directly on the ﬁt of the
individual ligand to the density) is capable of identifying 41%
of the 119 ligands (Fig. 2c). When combined by simple
summation with the Z score based on correlation coefﬁcient,
68%ofthe top-rankedligands are the correctligands (Fig.2d).
We examined how the accuracy of identiﬁcation varies with
the number of possible ligands considered. Fig. 2(e) shows that
if all 200 of the most common ligands are considered, then
48% of the top-ranked ligands are correct. If only 31 ligands
are considered (Fig. 2f), 90% of the top-ranked ligands are
correct.
4. Conclusions
We ﬁnd that our combination of two measures of the char-
acteristics of ligand density, a Z score based on the correlation
of the density with model density from ﬁtted ligands and a Z
score based on the correlation of the ﬁngerprint of the density
with model ﬁngerprints of the same ligands, can be of
considerable utility in identifying the correct ligand. The
summed Z scores Zi that are used can be converted to
approximate estimates of relative probabilities with
Pi ’ expð Z
2
i =2Þ; ð2Þ
allowing a probabilistic assessment of the ranking of ligands
that may correspond to the experimental density. This in turn
allows the construction, for example, of a list of all the ligands
with probability greater than 0.2 or a list of the ligands that,
considered together, make up a cumulative probability of 0.5.
If there are only a few possible ligands to consider and these
ligands are dissimilar in shape, then this approach can reliably
identify which ligand is present, as in Fig. 2(f). If there are
many ligands, then the identiﬁcation will consist more often of
a group of ligands that are similar to each other, any of which
might be the ligand present in the crystal structure.
There are a number of improvements that might be made to
this method. Probably the most important one will be to
include the contacts between ligand and macromolecule and
other compounds present in the crystal in the scoring of the ﬁt
of the ligands. Many of the alternatives for ligand placement
are likely to form implausible contacts, allowing them to be
eliminated or at least reduced in probability. Other improve-
ments might include resolution-dependent and possibly noise-
dependent tables of correlations of model ligands and ligand
density and the use of difference maps after ﬁtting to evaluate
the quality of ﬁt of a ligand to density.
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